Table 1.
Study group | ||||
---|---|---|---|---|
LVLVs | IVLVs | HVLVs | ||
Age (years)α | 27.5 (23–32) | 28.5 (28–32) | 35 (29–38) | |
Gender | Female | 5 | 5 | 5 |
Male | 5 | 5 | 5 | |
Risk group | Discordant couple | 8 | 8 | 8 |
MSM | 1 | 1 | 1 | |
Other heterosexual | 1 | 1 | 1 | |
Clade | A1 | 5 | 5 | 5 |
C | 3 | 3 | 3 | |
D | 2 | 2 | 2 | |
Country | Kenya | 1 | 1 | 1 |
Rwanda | 3 | 3 | 3 | |
South Africa | 1 | 1 | 1 | |
Uganda | 3 | 3 | 3 | |
Zambia | 2 | 2 | 2 | |
Mean VL | 909.86 (86.16–1426.02) | 12744.535 (9163.02–25803.85) | 114331.03 (81899.77–268402.30) | |
Mean CD4 count | 710.345 (561.37–817.22) | 533.955 (424.95–584.08) | 506.085 (365.42–692.21) |
Continuous variables shown as median (interquartile range), other variables expressed as count.
Wilcoxon test (p = 0.183).